BioMed Central Blog

Journal of Angiogenesis Research publishes first articles

The first articles published in Journal of Angiogenesis Research today cover a wide range of angiogenesis related topics, reflecting the journal’s aim of providing a pivotal platform for researchers in this area. Dr Meadows and colleagues examine the role of Akt signalling factors in early embryonic heart development, while Professor Mross and colleagues assess the cancer drug vandetanib on tumor vasculature in colorectal and liver cancer patients, and Professor Ribatti provides an overview on the role of William Harvey in the circulation of blood.

Angiogenesis, the growth of new blood vessels, is a key process occurring in the progression of diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. The rapid dissemination and implementation of advances in the field of angiogenesis will impact significantly on the understanding and treatment of these diseases. “For these reasons and due to the continual expansion of this area of biomedical research, we are proud to announce the launch of Journal of Angiogenesis Research.” say Editors-in-Chief, Mark Slevin, Yihai Cao and Jan Kitajewski.

If you are interested in this area of research, please visit the journal homepage and if you would like to receive regular emails detailing the most recently published articles then please sign up for article alerts.

Posted by Anne Braae at 10:55    Comments (0)